US FDA approves NeurogesX's Qutenza patch
17 November 2009
Katie McQue
Please Login to read the full article.
17 November 2009
Katie McQue
katie.mcque@informa.com
The US FDA has approved NeurogesX's topical anaesthetic Qutenza (capsaicin) 8% patch for the management of neuropathic pain due to postherpetic neuralgia. This is NeurogesX's first product to be approved by the US agency.
Post-herpetic neuralgia is pain that persists after the rash has cleared...
Please Login to read the full article.
RELATED CONTENT
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
